Drug Shortage Report for FLOMAX CR

Last updated on 2024-01-24 History
Report ID 210443
Drug Identification Number 02270102
Brand name FLOMAX CR
Common or Proper name FLOMAX CR
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Market Status CANCELLED POST MARKET
Active Ingredient(s) TAMSULOSIN HYDROCHLORIDE
Strength(s) 0.4MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 3X10
ATC code G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-11-24
Actual start date
Estimated end date 2024-02-05
Actual end date 2024-01-23
Shortage status Resolved
Updated date 2024-01-24
Company comments Demand increase due to stock out multiple generics
Health Canada comments
Tier 3 Status No
Contact Address 5180 SOUTH SERVICE ROAD
BURLINGTON, ONTARIO
CANADA L7L 5H4
Company contact information 1800 263 2425

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-01-24 English Compare
v9 2024-01-23 French Compare
v8 2024-01-23 English Compare
v7 2024-01-23 English Compare
v6 2023-11-25 English Compare
v5 2023-11-21 French Compare
v4 2023-11-21 English Compare
v3 2023-11-21 English Compare
v2 2023-11-16 French Compare
v1 2023-11-16 English Compare

Showing 1 to 10 of 10